Trump Administration Examines the Use of Psychedelics in Medicine
Health

Trump Administration Examines the Use of Psychedelics in Medicine

منبع تصویر: thehill.com

By 2 min Read time 53,262

The Trump administration is seriously exploring the potential use of psychedelics in the medical field. This initiative is influenced by the "Make America Healthy Again" (MAHA) movement and reflects a shift in approach regarding mental health and alternative treatments.

Recent Developments in Psychedelic Research

This examination began when the U.S. Food and Drug Administration (FDA) held a public meeting last September. At this meeting, over 200 advocates and researchers discussed the use of psychedelics in treating various conditions such as depression and anxiety disorders. This topic has recently garnered more attention and is being considered seriously in the medical world as an option.

The Role of Psychedelics in Medical Treatments

The use of psychedelics in medicine as a therapeutic method has gradually been gaining acceptance in recent years. Research indicates that some of these substances can help improve mental conditions and reduce symptoms of certain diseases. Among these substances are "nitrous oxide" and "psilocybin," which have shown positive effects in reducing symptoms of depression and anxiety in trials.

While some doctors and researchers welcome this approach, critics also express concerns about the side effects and long-term impacts of these substances. For this reason, researchers and relevant institutions are working to confirm the safety and efficacy of these treatments through further testing and studies.

The public's attention to this issue is also due to the fact that many patients are turning to alternative and natural treatments, especially when traditional therapies have failed to help them recover. Therefore, the government and relevant institutions are rapidly investigating and researching this field to provide more effective solutions for improving mental health.

Source: thehill.com